從山東疫苗案談「疫苗流通和預防接種管理條例」修改之進步與缺陷【本期企劃】 試閱
Looking at the Progress and Defects of the Revision of “Vaccine Circulation and Vaccination Management Regulations” from the Shandong Vaccine Case
山東疫苗案爆發後,中國國務院通過了新的「疫苗流通和預防接種管理條例」,並進一步提出相關意見。本文通過對比新舊兩版條例的差異,發現新條例的優勢,同時分析新條例施行後疫苗損害救濟方面仍存在諸多不足,以期更好地完善疫苗管理制度。
After the Shandong vaccine case broke out, the State Council passed the new “Vaccine Circulation and Vaccination Management Regulations” and further put forward relevant opinions. This article compares the differences between the two editions of the old and new regulations to discover the advantages of the new Regulations. At the same time, it analyzes the deficiencies in vaccine damage relief in the new situation in order to better improve the vaccine management system.
038-047